FigureAsia 35 Under 35 · Healthcare
Hoang Minh Hieu Nguyen
Age 25 · Neurodegeneration research and telemedicine access · Stanford, United States
Vietnamese medical trainee who contributed to 2025 neurodegeneration research and helped establish a telemedicine pathway serving a rural Kenyan hospital.
- Approximate age at 31 December 2025
- 25
- Field
- Healthcare
- Country or region
- Stanford, United States
- FigureAsia U35 Assessment
- 80.0 / 100
Profile
Career and documented record
Hoang Minh Hieu Nguyen has built an early career across two very different forms of healthcare contribution. In 2025, he coauthored a PNAS study on neurodegeneration, adding to a laboratory record in the biology of neural disease. At the same time, his global-health work helped establish a telemedicine pathway for a hospital in Longisa, Kenya, including access to specialist input around dialysis.
The combination is important because it refuses a false choice between frontier research and delivery. Nguyen's medical training gives him a clinical frame for both, while his role on an international telehealth advisory body places him inside the operational questions of connectivity, local capacity and referral continuity.
The public record does not provide a patient denominator, comparative outcomes or evidence that Nguyen alone created the Longisa programme. He is a young contributor in collaborative science and service, not the sole owner of either result. FigureAsia includes him because the work is completed, internationally relevant and unusually substantive for a 25-year-old physician in training — with its scale described no more strongly than the evidence allows.
FigureAsia selection
Why Hoang Minh Hieu Nguyen is on the list
FigureAsia selected Nguyen because his 2025 record joins rigorous biomedical inquiry to a concrete access pathway. His Vietnamese background and cross-border work embody the edition's view of the Asian diaspora as a source of reciprocal, not extractive, global engagement. The score is moderated by limited public outcome data and shared team attribution; the distinction lies in breadth, responsibility and trajectory rather than seniority.
Verified work
The 2025–26 record
Principal milestone
Born in 2000
Evidence record
Coauthor of a 2025 PNAS neurodegeneration study
Scale or implementation
Telemedicine pathway established for a rural Kenyan hospital, including dialysis access
Field context
The work in its field
Within neurodegeneration research and telemedicine access, the relevant test is whether a result can survive scrutiny of maturity, attribution, validity and practical fit. That distinction matters: completed evidence is not projected benefit, and individual responsibility is not interchangeable with the wider team’s achievement.
FigureAsia U35 Assessment
Assessment breakdown
80.0out of 100
Substantive 2025–2026 contribution
16 / 20
The score reflects completed 2025–26 work in neurodegeneration research and telemedicine access, assessed at the documented maturity of collaborative research and implemented telemedicine pathway.
Verified impact
10.5 / 15
Impact credit is limited to the measured study, regulatory, implementation or operating record stated in the profile; unsupported patient benefit is excluded.
Originality and distinction
8 / 10
The work creates or materially advances a distinctive capability within neurodegeneration research and telemedicine access rather than relying on title or institutional association.
Field and industry influence
7 / 10
The assessment recognises demonstrated effects on research, product development, care delivery or professional practice, with publicity alone carrying no weight.
Individual agency
8 / 10
Named authorship and the documented role of Medical Student and Global-Health Researcher establish individual responsibility while preserving credit for collaborators.
Durability and trajectory
4.5 / 5
The cited work forms part of a continuing programme, platform or research trajectory rather than a single uncompleted announcement.
Asian significance and global relevance
5 / 5
The Asian connection is material to the person's identity, operating base or populations served: Born in 2000 and raised in Di Linh, Vietnam; now training in medicine in the United States.
Clinical and scientific validity
5.6 / 7
Clinical and scientific validity is calibrated to collaborative research and implemented telemedicine pathway, with the profile retaining the evidence boundary attached to the result.
Safety, quality and responsible governance
5.6 / 7
Safety and governance credit reflects accurate regulatory language, study limitations, data stewardship and the refusal to turn early evidence into clinical certainty.
Translation and care-pathway fit
4.8 / 6
The work is scored for its demonstrated fit with a laboratory, regulatory, clinical, operational or public-health pathway, not for projected future adoption.
Access, equity and resource stewardship
5 / 5
Access credit reflects documented reach, capacity, affordability or inclusion while distinguishing service volume from proven clinical outcome.